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Seryl-tRNA synthetase (SerRS), an essential enzyme
for translation, also regulates vascular development.
This ‘‘gain-of-function’’ has been linked to the UNE-S
domain added to vertebrate SerRS during evolution.
However, the significance of two insertions also spe-
cific to higher eukaryotic SerRS remains elusive.
Here, we determined the crystal structure of human
SerRS in complex with Ser-SA, an aminoacylation
reaction intermediate analog, at 2.9 A˚ resolution.
Despite a 70 A˚ distance, binding of Ser-SA in the cat-
alytic domain dramatically leverages the position of
Insertion I in the tRNA binding domain. Importantly,
this leverage is specific to higher eukaryotes and
not seen in bacterial, archaeal, and lower eukaryotic
SerRSs. Deletion of Insertion I does not affect tRNA
binding but instead reduce the catalytic efficiency
of the synthetase. Thus, a long-range conformational
and functional communication specific to higher
eukaryotes is found in human SerRS, possibly to
coordinate translation with vasculogenesis.
INTRODUCTION
As a member of the aminoacyl-tRNA synthetase family, seryl-
tRNA synthetase (SerRS) catalyzes the aminoacylation reaction
that charges serine onto its cognate tRNA for protein synthesis
(Schimmel, 1987). This evolutionarily conserved essential reac-
tion happens in two steps: in the first step, serine is activated
by ATP to form serine-adenylate (Ser-AMP) as the enzyme-
bound reaction intermediate; in the second step, the seryl moiety
on Ser-AMP is transferred to the 30 of the cognate tRNA to
generate the final product Ser-tRNASer to be delivered to the
ribosome. The dimeric SerRS belongs to class II tRNA synthe-
tases (Cusack et al., 1991; Ribas de Pouplana and Schimmel,
2001; Schimmel and Ribas de Pouplana, 2001; Wu and Gross,
1993), whose catalytic domain contains a seven-stranded anti-
parallel b sheet and three conserved sequence motifs: motif 1
forms the dimer interface, whereas motifs 2 and 3 contain active
site residues critical for aminoacylation (Belrhali et al., 1994;2078 Structure 21, 2078–2086, November 5, 2013 ª2013 Elsevier LtdChimnaronk et al., 2005; Cusack et al., 1990, 1996; Itoh et al.,
2008; Leberman et al., 1991). Unlike most other tRNA synthe-
tases, SerRS does not identify the anticodon, but instead recog-
nizes the long variable arm that is unique to tRNASer (Asahara
et al., 1994; Heckl et al., 1998; Normanly et al., 1992; Sampson
and Saks, 1993; Soma and Himeno, 1998; Wu and Gross,
1993). The recognition is achieved by the N-terminal tRNA bind-
ing domain (TBD) which, in all organisms except for methano-
gens, is composed of two long a helices protruding away from
the catalytic/aminoacylation domain (AD). The TBD from one
subunit of the SerRS dimer interacts with tRNASer at the variable
arm and the TcC loop to direct the 30-CCA end to enter the
active site of the other subunit (Biou et al., 1994; Cusack et al.,
1996). In addition to charging tRNASer, SerRS also serylates
the selenocysteine-specific tRNA (tRNASec) to participate in the
translational incorporation of selenocysteine—the 21st amino
acid—into selenoproteins in all domains of life (Amberg et al.,
1996; Commans and Bo¨ck, 1999).
While preserving its classic role in protein synthesis, verte-
brate SerRS developed a second essential function in vascular
development through acquisition of a C-terminal UNE-S domain
that is dispensable for aminoacylation (Amsterdam et al., 2004;
Fukui et al., 2009; Herzog et al., 2009; Xu et al., 2012). From
fish to humans, the UNE-S domain harbors a nuclear localization
signal (NLS) sequence that directs SerRS from the cytoplasm
into the nucleus to control the expression of vascular endothelial
growth factor-A (VEGFA; Xu et al., 2012) Mutations that disrup-
ted SerRS nuclear localization caused abnormal vasculature
and premature death in zebrafish. Prior to the acquisition of
the UNE-S domain is the insertion of two sequence motifs that
are present in all vertebrates as well as in some invertebrates.
The first (Insertion I) of 23 residues is inserted between the two
long a helices in the TBD and is distal to the active site. The sec-
ond (Insertion II), containing only nine residues, is located
between motifs 1 and 2 in the AD. No functional annotation
has been reported for these insertions. Interestingly, both inser-
tions were completely or partially disordered in the crystal struc-
ture of the free human SerRS (Xu et al., 2012).
To gain more insight on human SerRS, we set out to determine
the crystal structure of human SerRS in complex with its
aminoacylation reaction intermediate analog. Remarkably, bind-
ing of the adenylate analog induced a conformational change of
the TBD not seen in bacterial, archaeal, and lower eukaryotic
SerRSs. The binding also induced structural ordering of bothAll rights reserved
Table 1. X-Ray Crystallography Data Collection and Refinement
Statistics
Data Collection
Cell parameters (A˚) a = 167.074, b = 167.074, c = 65.156
a = b = 90, g = 120
Space group P321
Wavelength (A˚) 0.9794
Resolution (A˚) 50 (2.95)–2.9
No. of all reflections 233,550
No. of unique reflections 23,503
Completeness (%) 99.9 (100)
Redundacy 9.9 (10.1)
I/sI 6.2 (2.7)
Rmerge (%) 9.4 (66.9)
Refinement
Resolution (A˚) 50 – 2.9
Total no. of reflections 23,501
No. of reflections used 22,293
Rwork / Rfree (%) 25.5/26.8
No. of atoms 3,875
Protein 3,836
Water 3
Ser-SA 1
PO43 1
Mg2+ 2
Rmsds
Bond lengths (A˚) 0.007
Bond angle () 1.0
Average B-factors (A˚2) 69.7
Numbers in parentheses represent highest-resolution shell.
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Evolution of SerRS Structure and Dynamicsinsertions, including Insertion I that is 70 A˚ away from the adeny-
late binding site. Further structural and functional analyses
suggest that Insertion II, albeit close to the active site, plays a
minimal role on aminoacylation, whereas Insertion I mediates a
long-range conformational and functional communication with
the active site.
RESULTS
Ser-SA Induces Conformational Change of TBD Specific
to Human SerRS
The crystal structure of human SerRS in complex with Ser-AMP
analog 50-O-(N-(L-seryl)-sulfamoyl)adenosine (Ser-SA) is solved
at 2.9 A˚ resolution (Table 1). The P321 trigonal crystal contains
one subunit of SerRS in the asymmetric unit and the structure
of the dimeric protein can be generated through crystallographic
symmetry operation (Figure 1A). Except for the C-terminal
UNE-S domain, conformation of the 514-residue protein, in-
cluding Insertions I (G75–N97) and II (K253–N261), is completely
resolved (Figure 1A). Compared with the crystal structures of the
free human SerRS we determined previously (Xu et al., 2012),
binding of Ser-SA in the active site induces a prominent confor-
mational change and a tightening of the TBD (Figure 1B; top). TheStructure 21, 2078–20conformational change acts as a lever that dramatically affected
the position of Insertion I in the complex versus in the free protein
(Figure S1 available online). In contrast, no obvious conforma-
tional change of the TBD resulting from Ser-SA or ATP binding
was observed in any previous structures of SerRS from organ-
isms including Thermus thermophilus (bacterium; Biou et al.,
1994; Cusack et al., 1996; Fujinaga et al., 1993), Pyrococcus
horikoshii (archaeon; Itoh et al., 2008), Candida albicans
(O’Sullivan et al., 2001), and Trypanosoma brucei (lower eukary-
otes; Figure 1B; bottom). Thus, the Ser-SA-induced conforma-
tional change of the TBD is specific to human SerRS.
Free Human SerRS Has a Special Open Conformation
A closer examination of the structures indicated that the tight
conformation of the TBD in Ser-SA-bound human SerRS is not
unique. In fact, ligand-bound or not, the TBD in SerRS from
T. thermophiles, P. horikoshii, C. albicans, or T. brucei all adopt
the similar tight conformation (Figure S2). What is special is the
open and flexible conformation of the TBD in the free human
SerRS. Indeed, multiple conformations and varies degrees of
openness of the TBD were observed in the crystal structures of
the free human SerRS (Xu et al., 2012). The conformational flex-
ibility of the TBD was captured as conformational variability due
to the differences in crystal lattice interactions for each TBD (Fig-
ure S3). Importantly, upon Ser-SA binding, the TBD adopts a
conformation that is more closed than any one of the TBD con-
formations found in the free SerRS (Figure S1), suggesting that
the open and flexible conformations of TBD can be tightened
and leveraged upon Ser-SA binding.
The Communication between AD and TBD in Human
SerRS Involves Residues Specific to Higher Eukaryotes
An important question is how the active site, upon Ser-SA bind-
ing, is communicated with TBD in human SerRS. In fact, Ser-SA
is bound in the active site of human SerRS via residues that are
highly conserved throughout evolution (Figure S4). Interestingly,
extra electron densities are present in the active site, which most
likely correspond to two Mg2+ ions mediating interactions
between Ser-SA and the protein (Figure S4). The first Mg2+ is
located in a conserved position that was also seen in the cocrys-
tal structure of the SerRS/Ser-SA complex from C. albicans.
The Mg2+ coordinates a sulfamoyl oxygen of Ser-SA with the
carboxyl side chain of E391 and the hydroxyl side chain of
S394. (As seen in the C. albicans structure, the rest of the octa-
hedral coordination for the Mg2+ ion is through water molecules
that do not resolve at this resolution of 2.9 A˚.) The second Mg2+
ion is, however, in a special position not seen in the C. albicans
structure and coordinates the amide oxygen of Ser-SA with the
carboxyl side chain of E246, which in turn forms a hydrogen
bond with the carboxamide side chain of Q242. This Mg2+-medi-
ated interaction induces the helical formation of a10, where E246
and Q242 are located (Figures 2A and 2B). Also located on a10
are two residues—Q239 and L240—that are important for
engaging the TBD (Figure 2A and see below).
To understand which residues in human SerRS are involved in
mediating the conformational change of TBD in respond to Ser-
SA binding, we examined the ‘‘hinge’’ region where the TBD is
connected to the AD (Figure 1B). We found two residues, R133
and E134, from the TBD domain, whose side chains interact86, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2079
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Figure 1. Overall Structure of Human SerRS
in Complex with Ser-SA and the Conforma-
tional Change of TBD
(A) Crystal structure of human SerRS bound with
Ser-SA. The secondary structure elements are
labeled. Inset: Structure of the dimeric SerRS with
the second subunit generated by crystallographic
symmetry operation shown in gray.
(B) Ser-SA induced conformational change of the
TBD is specific to human SerRS. The Ser-SA bound
and free structures from human (PDB IDs 4L87 and
3VBB), C. albicans (PDB IDs 3QO8 and 3QNE),
T. brucei (PDB IDs 3LSS and 3LSQ), P. horikoshii
(PDB IDs 2DQ0 and 2ZR3), and T. thermophilus
(PDB IDs 1SET and 1SRY) are superimposed at
the AD. Free SerRSs are shown in gray and the
Ser-SA bound SerRSs in colors.
See also Figures S1–S3.
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Evolution of SerRS Structure and Dynamicswith residues from the ADonly when Ser-SA is bound (Figures 2A
and 2B). In particular, the guanidine side chain of R133 forms a
hydrogen bondwith the carboxamide side chain of Q235 on helix
a9; and the carboxyl side chain of E134 form a hydrogen bond
with the main chain N of L240 on a10. The only hydrogen-
bonding interactions found in the free SerRS to bridge the TBD2080 Structure 21, 2078–2086, November 5, 2013 ª2013 Elsevier Ltd All rights reservedwith the AD is between the main chain O
of E134 and the imidazole side chain of
H371 (preceding b10) and between the
main chain N of V2 and the main chain O
of Y401 (preceding a13; Figure 2B). Upon
Ser-SA binding, these two interactions
are strengthened, as evidenced by short-
ened hydrogen bonding distances, and
are used to engage another residue Q239
on a10 to further enhance the domain-
domain interaction (Figure 2A). Therefore,
Ser-SA binding induces the helical forma-
tion of a10 that allows its residues Q239
and L240 and residue Q235 on a9 to
engage the TBD to rotate toward the active
site (Figures 2A and 2B). Importantly, the
residues involved in mediating the confor-
mational change of TBD (i.e., R133, E134,
Q235, Q239, L240, Q242, E246, and
H371) are strictly conserved in all verte-
brate SerRSs (Figure 3).
TBD Interactions Shift from a13 in
Lower Organisms to a9–a10 in
Human SerRS
To understand how the tight conformation
of the TBD is achieved in bacterial,
archaeal, and lower eukaryotic SerRSs,
we examined the crystal structures of
SerRS from T. thermophiles, P. horikoshii,
C. albicans, and T. brucei to identify resi-
dues that mediate the TBD-AD interaction.
In each structure, we found multiple
hydrogen-bonding interactions betweenthe two domains and, in contrast to the situation in human
SerRS, the interactions are essentially unaffected by ligand bind-
ing (Figures 2C–2F and Figure S5). Interestingly, in all nonhuman
SerRS structures, an a helix that is equivalent to a13 in human
SerRS is key for the domain-domain interaction: in C. albicans,
Y376 on a13 and T374 immediately preceding a13 interact
Figure 2. Ser-SA-Induced Conformational Change in Human SerRS Is Caused by Shifting the TBD-AD Interactions from a13 in Lower
Organisms to a9–a10 in Human SerRS
The hydrogen bonding interactions in the ‘‘hinge’’ region mediating TBD (yellow) and AD (green) in crystal structures of (A) human SerRS bound with Ser-SA (PDB
ID 4L87), (B) ligand-free human SerRS (PDB ID 3VBB), (C) C. albicans SerRS bound with Ser-SA (PDB ID 3QO8), (D) T. brucei SerRS bound with ATP (PDB ID
3LSS), (E) P. horikoshii SerRS bound with Ser-SA (PDB ID 2DQ0), and (F) T. thermophiles SerRS bound with Ser-SA (PDB ID 1SET). The secondary structures are
labeled in gray.
See also Figures S4 and S5.
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Evolution of SerRS Structure and Dynamicswith M1 and N110 of the TBD, respectively (Figure 2C). The M1-
Y376 interaction also involves R379 (as well as N380 in the
ligand-free structure) on a13 (Figure 2C); in T. brucei, T392 pre-
ceding a13 interacts with N138 of the TBD, while N364, the res-Structure 21, 2078–20idue equivalent to H371 in human SerRS, interacts with L134
(Figure 2D); in P. horikoshii, T378 preceding a13 interacts with
N108 of the TBD, while W380 and R384 on a13 interact with
TBD residues M1, W104, and L106 (Figure 2E); similarly in86, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2081
Figure 3. Conservations of Key Residues Involved in the TBD-AD Interaction and of the Insertions I and II in Higher Eukaryotes
Key residues involved in communication of TBD and AD are highlighted in yellow (TBD) or in green (AD). The vertebrate-specific Insertions I and II are shown in
salmon.
Structure
Evolution of SerRS Structure and DynamicsT. thermophiles, W355 and R359 on a13 interact with TBD resi-
dues M1, L99 and V101 (Figure 2F). The only interdomain
hydrogen-bonding interaction found in human SerRS that is
also conserved in other SerRSs is the V2-Y401 backbone
interaction, which is equivalent to M1-Y376, M1-W380, and
M1-W355 interaction in C. albicans, P. horikoshii, and T. thermo-
philes SerRS, respectively (Figures 2A, 2C, 2E, and 2F). [This
interaction is not found in T. brucei, instead, the L134–N364
interaction similar to the E134–H371 interaction in human SerRS
is found in T. brucei (Figures 2A and 2D).] Remarkably, except for
the V2-Y401 backbone interaction, a13 is no longer used by hu-
man SerRS to interact with the TBD. Instead, a9 and especially
a10 that are closer to the active site are used to create the
communication between the active site and the TBD in human
SerRS (Figure 2A).
Ser-SA Binding Stabilized the Higher Eukaryote-
Specific Insertions in Human SerRS
Ser-SA binding not only engages the TBD, but also stabilizes the
conformation of Insertion I, which is located at the far end of the2082 Structure 21, 2078–2086, November 5, 2013 ª2013 Elsevier LtdTBD approximately 70 A˚ away from the active site (Figure 1A).
This suggests that the communication between the active
site and the TBD is long range and not limited to the ‘‘hinge’’
region. Insertion I connects the two long a helices (a3 and
a5) of the TBD with a long loop (G75-T91) followed by a short
a helix (a4; A92-N97). Interestingly, part of the Insertion I
sequence contains one leucine residue at every five amino acids
(L85SFDDL90TADAL95AN). This leucine-rich motif provides
extensive hydrophobic interactions with residues from both a3
and a5 (Figure 4A). For example, L85 interacts with L109 of a5;
L90 interacts with both L56 of a3 and V106 of a5; and L95 inter-
acts with L59 of a3 and L103 of a5 (Figure 4A). These hydropho-
bic interactions not only stabilize the conformation of Insertion I,
but also that of the two long helices of the TBD, which are con-
nected to the active site via the opposite ends (Figure 2A).
Insertion II in the aminoacylation domain is also resolved as a
result of Ser-SA binding (Figure 1A). This insertion forms a loop
structure connecting the antiparallel b4 and b5 strands. It pro-
trudes out of the aminoacylation domain to cross over the dimer
interface and sits on top of the motif 2 loop of the other subunitAll rights reserved
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Figure 4. Structural and Functional Analyses of Insertions I and II
(A) Leucine-rich motif of Insertion I (salmon) forms extensive hydrophobic interactions with residues from a3 and a5 (yellow).
(B) Structural environment of Insertion II (salmon) near the dimer interface and the active site.
(C) Aminoacylation assay indicating that deletion of Insertion I has a larger effect on SerRS aminoacylation activity than deletion of Insertion II.
(D) ATP-PPi exchange assay confirming the effect of Insertion I on the active site.
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Evolution of SerRS Structure and Dynamics(Figure 4B). Therefore, Insertion II is close to the active site of the
other subunit and seems to stabilize the dimerization interface.
Indeed, the dimer interface is increased from 1,126 ± 36 A˚2 to
1,615 A˚2 as a result of Ser-SA binding and the structural ordering
of Insertion II.
Insertion I Functionally Communicates with the
Active Site
The long-range conformational communication between the
active site and Insertion I suggested that Insertion I may affect
the enzymatic activity of SerRS. The proximity of Insertion II to
the active site across the dimer also raised the same possibility.
To test the effect of the insertions on aminoacylation, we created
deletion mutants that remove Insertion I or II or both. Interest-
ingly, despite the fact that Insertion II is closer to the active
site, removal of Insertion I (DG75–N97) has a greater effect
than removal of Insertion II (DG254–S261) on the overall amino-
acylation activity of human SerRS as measured by the incorpo-
ration of serine onto tRNASer (Figure 4C). Kinetics analysis
indicated that DG75–N97 SerRS had a 19-fold decrease in
maximum catalytic rate (kcat) and a 2.3-fold enhancement in
tRNA binding (decrease in Km) to give an 8-fold decrease in the
overall catalytic efficiency (kcat/Km). In contrast, DG254-S261
SerRS only had a 2-fold decrease in kcat and a 1.5-fold decrease
in Km to give a negligible 1.4-fold decrease in kcat/Km (Table 2).
Simultaneous removal of both insertions had amore pronounced
effect (Figure 4C; Table 2).
The kinetic parameters from the aminoacylation assay sug-
gested that Insertions I and II are unnecessary, and perhaps
even slightly cumbersome, for tRNA binding. To confirm thisStructure 21, 2078–20interpretation, we performed the nitrocellulose filter binding
assay to directly measure the tRNA binding constants (Kds) of
SerRS and its deletion mutants. The results are highly consistent
with those from the aminoacylation assay and show that
removal of either or both insertions would enhance tRNA binding
(Table 2).
To confirm that Insertion I does remotely affect the active site,
we also measured the serine-dependent ATP-PPi exchange
activity of SerRS (and its deletion mutants) in the absence of
tRNA. Consistent with the result from the tRNA aminoacylation
assay, removal of Insertion I more dramatically affected the
catalytic activity than removal of Insertion II (Figure 4D). There-
fore, both a structural and a functional interplay exist between
Insertion I and the active site.
DISCUSSION
It has been well established that vertebrate SerRS has
expanded its function beyond aminoacylation to also play an
essential role in vascular development (Amsterdam et al.,
2004; Fukui et al., 2009; Herzog et al., 2009; Xu et al., 2012).
The functional expansion is dependent on the UNE-S domain
that was added to SerRS during the invertebrate-to-vertebrate
transition when the closed circulatory system was developed.
Using its embedded NLS, the UNE-S domain functions to facil-
itate the translocation of SerRS from the cytoplasm into the nu-
cleus to regulate VEGFA expression. Based on our sequence
analysis (Figure 3), the open and flexible conformation of the
TBD found in human SerRS should be conserved in all verte-
brates, and perhaps even in some insects such as the yellow86, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2083
Table 2. Kinetic Parameters for tRNASer of HumanWild-Type and
Mutant SerRS Proteins
Enzyme Km (mM)
a kcat (s
1)a
Relative
kcat/Km
a Kd (mM)b
Wild-type 0.77 ± 0.25 0.43 ± 0.040 1 0.37 ± 0.010
DG254–N261 0.51 ± 0.23 0.20 ± 0.025 0.72 0.24 ± 0.028
DG75–N97 0.33 ± 0.40 0.025 ± 0.004 0.13 0.19 ± 0.016
DG75–N97
DG254–N261
0.13 ± 0.10 0.005 ± 0.001 0.07 0.099 ± 0.019
aDetermined by aminoacylation assay.
bDetermined by nitrocellulose filter binding assay.
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Evolution of SerRS Structure and Dynamicsfever mosquito Aedes aegypti, because they contain all the key
residues for engaging the TBD in response to ligand binding and
therefore do not need to stay in the closed conformation to sup-
port catalysis. Although the mechanism of how SerRS regulates
VEGFA in the nucleus is not yet clear, it is tempting to speculate
that the open conformation of SerRS specific to higher eukary-
otes is developed or is used to accommodate the nuclear func-
tion of SerRS.
Also not known are the critical domain(s) or site(s) in SerRS
used for supporting its nuclear function. In this regard, both
Insertions I and II are newly added motifs that are concomitantly
present in all vertebrates and in some but not all invertebrates;
both insertions are rich in charged residues and have surface lo-
cations ideal for providing protein-protein or protein-nucleic acid
interactions and, from our charging kinetic and tRNA binding an-
alyses, it is clear that the insertions are not meant for enhancing
tRNA binding. It would be interesting to test in future work if the
two insertions are important for the nuclear function of SerRS in
regulating vasculogenesis.
One of the advantages to expand the ‘‘functionome’’ of tRNA
synthetases was thought to provide coordination between
protein synthesis and other cellular processes important for
higher organisms. For example, the nuclear import of human
tyrosine tRNA synthetase is controlled by the cytoplasmic level
of tRNATyr to link the role of TyrRS in the nucleus with the
demands of protein synthesis in the cytoplasm (Fu et al.,
2012). Our observation of a higher eukaryote-specific, long-
range conformational and functional communication between
the enzymatic core and a potential functional site in SerRS for
regulating vasculogenesis raises the possibility that this
communication is important for coordinating translation with
vasculogenesis.
Conclusions
Crystal structure analyses of human SerRS revealed that the
TBD adopts open and flexible conformations that are specific
to SerRSs from higher eukaryotes. Upon Ser-SA binding, the
TBD is tightened through interacting with a newly formed a helix
(a10) in the AD near the active site. The conformational change
of the TBD is leveraged to dramatically change the position
of a higher eukaryote-specific motif—Insertion I—that may be
involved in the function of SerRS in vascular development.
Inversely, deletion of Insertion I allosterically affected the enzy-
matic activity of SerRS, indicating a long-range conformational
and functional communication between the active site and Inser-2084 Structure 21, 2078–2086, November 5, 2013 ª2013 Elsevier Ltdtion I, which may serve to coordinate the dual roles of SerRS in
protein synthesis and in vascular development.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human SerRS gene was cloned into pET20b vector (Novagen) with a C-termi-
nal 63 His tag and overexpressed in E. coli BL21 (DE3) cells. The cells were
lysed by M-110L Microfluidizer Processor (Microfluidics) in 25 mM HEPES-
Na pH 7.5, 300 mM NaCl, 20 mM imidazole, and 5% glycerol. The cell lysates
were centrifuged at 25,000 rpm for 40 min. The soluble fractions were applied
to Ni-NTA column (QIAGEN), and the bound SerRS was eluted by 250 mM
imidazole. After buffer exchange into 25 mM HEPES-Na pH 7.5, SerRS was
further purified by ion exchange chromatography using a Resource Q column
(GE Healthcare) with a NaCl gradient from 0 to 1 M (SerRS was eluted around
250 mM NaCl), and by size exclusion chromatography using a HiLoad 16/60
Superdex 200 prep grade column (GE Healthcare). The purified human SerRS
was collected and concentrated for crystallization. The Insertion I and Insertion
II deletion mutants of SerRS were constructed by site-directed mutagenesis
and purified using the same methods.
Crystallization
High-throughput crystallization screen was performed using Mosquito liquid
transfer robot (TTP Labtech) and the sitting-drop vapor diffusion method.
Crystals were obtained at room temperature by mixing 0.1 ml human SerRS
(10 mg/ml, pre-incubated with 250 mM Ser-SA in buffer containing 25 mM
HEPES-Na pH 7.5,100 mM KCl, 10 mM MgCl2, and 5 mM dithiothreitol
[DTT]) with 0.1 ml reservoir solution (20% PEG 3350, 0.2 M ammonium fluoride
or ammonium formate, and 0.1 M HEPES pH 7.0) and by equilibrating the
mixture against 70 ml reservoir solution. The final crystals used for data collec-
tion were further optimized by adding 0.5% w/v n-dodecyl-b-D-maltoside into
the mixture.
Crystal Data Collection, Structure Determination, and Refinement
Crystals were cryoprotected with 15% glycerol added to the reservoir solution
and flash-frozen with liquid nitrogen. A 2.9 A˚ resolution data set was collected
at 100 K on beamline BL7-1 at Stanford Synchrotron Radiation Lightsource
with an ADSC Q315 detector. The crystal belongs to space group P321 with
unit cell dimensions a = b = 167.074 A˚ and c = 65.156 A˚, a = b = 90, g =
120. Diffraction data were processed, integrated, and scaled with HKL2000
(Otwinowski and Minor, 1997). The structure of human SerRS and Ser-SA
complex was solved by molecular replacement using the human SerRS apo-
structure (Protein Data Bank [PDB] ID 3VBB; Xu et al., 2012) as a search model
and the PHASER program (McCoy et al., 2007) from the CCP4 package
(CCP4, 1994). Iterative model building and refinement were performed using
Coot (Emsley and Cowtan, 2004) and Refmac5 (Murshudov et al., 1997)
to obtain the final model with Rwork of 25.5% and Rfree of 26.8% at 2.9 A˚
resolution.
Active Site Titration Assay
Active site titration assay was performed in 100 mM HEPES pH 7.5, 20 mM
KCl, 10 mM MgCl2, 50 mM ATP, 22.2 nM [g
-32P]-ATP, 20 mM L-serine, 2 mg/
ml pyrophosphatase (Roche), and 2 mM DTT as previously described (Beebe
et al., 2007; Xu et al., 2012) to determine the concentration of active enzymes.
ATP-PPi Exchange Assay
ATP-PPi exchange assay was performedwith 0.5 mMSerRS (WT ormutants) in
100 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2, 2 mM ATP, 500 mM
L-serine, 1 mM Na-PPi, 0.07 mCi Na-32PPi, and 2 mM DTT as described (Xu
et al., 2012).
Aminoacylation Assay
Human tRNASer was in vitro transcribed as previously described (Xu et al.,
2012). Aminoacylation assays were performed with 50 nM enzyme in 50 mM
HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2, 4 mM ATP, 2 mM [
3H]-L-serine,
20 mML-serine, 2mMDTT, 0.1mg/ml BSA, 4 mg/ml pyrophosphatase (Roche),
and 1 mM tRNASer transcript.All rights reserved
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In vitro transcribed human tRNASer was diluted to 25 pmol/ml, and dephos-
phorylated by calf intestine alkaline phosphatase at 37C for 1 hr. The dephos-
phorylated tRNASer was labeled with 30-32P by T4 polynucleotide kinase at
37C for 1 hr (Ambion’s Kinasemax kit), and spun through a G-25 column to
remove the unlabeled nucleotides. The labeled tRNA was re-annealed and
maintained in buffer containing 100 mM HEPES and 2 mM MgCl2. The filter
binding assay was performed by incubating different concentrations of SerRS
(wild-type or mutants) with 32P-labeled tRNASer mixed with cold tRNASer in
assay buffer (50 mM HEPES, 20 mM KCl, 4 mM MgCl2, and 2 mM DTT); after
incubation for 30 min, the mixtures were spotted on nitrocellulose filter mem-
brane (Millipore). The membranes were washed three times with 0.5 ml wash
buffer (25 mM HEPES, 10 mM KCl, and 4 mM MgCl2) before being air-dried.
The amount of bound tRNASer on the membranes wasmeasured using amulti-
purpose scintillation counter LS-6500 (Beckman Coulter).
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The PDB accession number for the atomic coordinates and structure factors of
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